Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadovist 1.0 vs Dotarem for MRI of distal lower limb osteomyelitis
2008-002741-23Phase 3Completed
- Sponsor
- BG Universitätsklinikum Bergmannsheil
- Start
- May 2008
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gadobutrol in osteomyelitis (OM), sponsored by BG Universitätsklinikum Bergmannsheil. Primary endpoint: Overall assessment of contrast enhancement. Started May 2008; status: completed.
02
Drugs
gadobutrol
03
Conditions
osteomyelitis (OM)
Beyond the preview
Go deeper on 2008-002741-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002741-23.